BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Gene editing

  FDA bolsters bespoke therapy framework with new draft safety guidelines

  The draft guidance supports the agency’s new pathway designed to speed up the development of custom gene therapies.

  April 14, 2026

   · 

  2 min read

   · 

  Gabrielle Masson
• Press Releases

  Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma

  Clinical Trial Seeks to Validate Novel Blood-Based Assay that Predicts Relapse Risk by Analyzing the Biologic Behavior of Remaining Cancer Cells, Addressing Critical Gaps in Current Minimal Residual Disease (MRD) Testing

  April 14, 2026

   · 

  6 min read
• Press Releases

  Kiora’s Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway

  April 14, 2026

   · 

  6 min read
• Press Releases

  BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum

  BioMark Comprehensive Metabolomics Assay Selected as Top Canadian Innovation for the CTS Beaver Den Innovation Award

  April 14, 2026

   · 

  4 min read
• Press Releases

  Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart

  April 14, 2026

   · 

  4 min read